ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
67 announcements with these filters
Inventurus Knowledge Solutions released investor FAQs regarding its investment in IKS WWMG MSO LLC. The update highlights physician recruitment and platform onboarding progress.
IKS subsidiary will acquire units in WWMG MSO LLC for USD 15 million (Rs.141 Crore). The strategic US investment strengthens its care enablement platform and market position.
Inventurus Knowledge Solutions will invest USD 15 million in IKS WWMG MSO LLC. This increases its shareholding from 48.02% to 63.49%.
Inventurus Knowledge Solutions granted 131,114 employee stock options to eligible staff. The options can be exercised at a Rs.1 share price during continued employment.
Inventurus Knowledge Solutions announced the approval of postal ballot resolutions with requisite majority. Members approved material subsidiary share pledges and guarantees for a wholly owned subsidiary.
Inventurus Knowledge Solutions filed its Annual Secretarial Compliance Report for FY 2025-26. The report confirms regulatory adherence with no material non-compliances or penalties observed.
IKS Health reported strong Q4 FY26 performance with 18.5% revenue growth (INR 857 cr). Strategy focuses on AI-native 'Platform Systems of Action' and integrating the TruBridge acquisition.
IKS Health delivered a strong FY26 with 20% revenue growth and significant margin expansion, though reported PAT was aided by one-time forex gains.
Inventurus Knowledge Solutions reappointed KKC & Associates LLP as internal auditors for twelve months. Vice President Saransh Mundra ceased being senior management but remains in IR.
Mr. Saransh Mundra will no longer be classified as Senior Management Personnel effective May 14, 2026. He continues to lead investor relations for the company.
Inventurus Knowledge Solutions re-appointed M/s KKC & Associates LLP as Internal Auditors for FY 2026-27. This routine administrative update ensures continued internal audit compliance.
Inventurus Knowledge Solutions (IKS Health) reported strong FY26 performance with 20% INR revenue growth and significant margin expansion (EBITDA 34%, PAT 23%). The firm is transitioning to an AI-native healthcare enablement platform.
Inventurus Knowledge Solutions acquired ARAI Solutions to enhance its AI technology stack. The move adds proprietary clinical reasoning and medical ontologies to its healthcare platform.
IKS Health reported 20% revenue growth to ₹3193.8 Crore for FY26. Profit After Tax surged 48% to ₹721.6 Crore, driven by robust healthcare platform scalability.
Inventurus Knowledge Solutions Ltd reported revenue from operations of ₹857.7 Cr (+18.5% YoY) and net profit of ₹206 Cr (+39.4% YoY) for Q4 FY26.
Inventurus Knowledge Solutions reported audited FY26 results and approved acquiring Arai Solutions for ₹11 Crore. The acquisition strengthens its healthcare-focused artificial intelligence capabilities.
Inventurus Knowledge Solutions Limited (IKS Health) announced a strategic multi-year partnership with Holyoke Medical Center, a 219-bed hospital in Massachusetts. The collaboration utilizes AI-driven solutions to reduce administrative burdens and optimize revenue cycles. This alliance aims to improve clinical efficiencies and financial stability for the independent community hospital.
Inventurus Knowledge Solutions Limited has scheduled a Board Meeting on May 13, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. Consequently, the trading window for designated persons remains closed from April 1, 2026, to May 15, 2026.
Inventurus Knowledge Solutions Limited has scheduled a Board Meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the year ended March 31, 2026. The trading window remains closed until May 15, 2026.
Inventurus Knowledge Solutions Limited (IKS Health) announced a strategic acquisition of US-listed TruBridge for an enterprise value of ₹5235.80 Crore ($557 million). The deal combines IKS's platform system of action with TruBridge's EHR system of record, creating a dominant integrated healthcare player. The transaction is expected to close within 90-120 days and be immediately EPS accretive.
IKS Health announced a $557M acquisition of TruBridge to dominate the U.S. rural healthcare market. Strategic shift from 'System of Action' to an integrated 'System of Record' model.
Inventurus Knowledge Solutions Limited has issued a Postal Ballot notice for shareholder approval. Resolutions include pledging or disposing of assets/shares of material subsidiaries and providing guarantees for facilities availed by its US-based wholly-owned subsidiary. Voting concludes on May 29, 2026.
Inventurus Knowledge Solutions Limited has issued a postal ballot notice seeking shareholder approval for a ₹6298.0 Crore borrowing facility and associated guarantees. The funds will primarily finance the acquisition of TruBridge, Inc. (Target) through its US subsidiary. Voting remains open from April 30 to May 29, 2026.
Inventurus Knowledge Solutions Ltd granted 12,700 employee stock options under its IKS ESOP Plan 2022. The options are exercisable at ₹1,505.20 each, representing an aggregate value of ₹1.91 Crore. The grant aims to incentivize and retain eligible employees through equity-based benefits.
IKS Health transforms into an integrated platform player through the $557M acquisition of TrueBridge, gaining a dominant EHR position in the $164B US rural hospital niche.
Inventurus Knowledge Solutions Limited (IKS Health) has announced an agreement to acquire TruBridge. The acquisition expands IKS Health's presence into the rural and community hospital segment and creates an integrated healthcare platform. The transaction is expected to close in Q2 FY 2027 and be EPS accretive in its first year.
Inventurus Knowledge Solutions Limited (IKS Health) has agreed to acquire US-based TruBridge, Inc. for $26.25 per share in cash. The deal, valued at approximately ₹2,688 Crore, strengthens IKS Health's presence in the rural and community-based healthcare market. The acquisition is expected to close in Q3 2026.
IKS Health to acquire TruBridge for $557M (Bid EV), creating a $698M revenue entity. Strategy focuses on AI-powered healthcare operating systems.
Inventurus Knowledge Solutions Limited's US subsidiary is acquiring NASDAQ-listed Trubridge Inc. for ₹4,690.00 Crore ($26.25/share). The acquisition diversifies the company into the SaaS EHR and revenue cycle management segments, serving 700+ hospitals. The transaction, expected to close within 180 days, will significantly expand the group's US market presence and consolidated asset base.
Inventurus Knowledge Solutions Limited's US subsidiary is acquiring Trubridge Inc. for ₹4,690 Crore ($26.25/share) in cash. The acquisition of the NASDAQ-listed healthcare IT firm enables IKS to offer integrated EMR and RCM solutions. The transaction is expected to close within 180 days, significantly expanding the company's US healthcare market presence.